Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s10096-020-04016-1 http://scihub22266oqcxt.onion/10.1007/s10096-020-04016-1 32856202!7452614!32856202     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32856202&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Eur+J+Clin+Microbiol+Infect+Dis 2021 ; 40 (2): 407-411 Nephropedia Template TP {{tp|p=32856202|t=2021. A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort |pdf=|usr=}}{{32856202}} gab.com Text A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort JO: Eur J Clin Microbiol Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32856202 #FOAvip This manuscript aims to present a treatment algorithm we applied to manage COVID-19 patients admitted to our hospital. During the study period, 2043 patients with suspected COVID-19 were admitted to the emergency department. Molecular tests indicated that 475 of these patients tested positive for COVID-19. We administered hydroxychloroquine plus doxycycline to mild cases (isolated at home) for 3 days and lopinavir plus doxycycline to moderate and severe cases (hospitalized) for 5 days. The overall case fatality rate was 4.2% (20/475). Twit Text FOAVip A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort ????Eur J Clin Microbiol Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32856202 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32856202 #FOAvip English Wikipedia <ref>{{Cite pmid|32856202}}</ref> A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort #MMPMID32856202 Cag Y; Icten S; Isik-Goren B; Baysal NB; Bektas B; Selvi E; Ergen P; Aydin O; Ucisik AC; Yilmaz-Karadag F; Caskurlu H; Akarsu-Ayazoglu T; Kocoglu H; Uzman S; Nural-Pamukcu M; Arslan F; Bas G; Kalcioglu MT; Vahaboglu H Eur J Clin Microbiol Infect Dis 2021[Feb]; 40 (2): 407-411 PMID32856202show ga This manuscript aims to present a treatment algorithm we applied to manage COVID-19 patients admitted to our hospital. During the study period, 2043 patients with suspected COVID-19 were admitted to the emergency department. Molecular tests indicated that 475 of these patients tested positive for COVID-19. We administered hydroxychloroquine plus doxycycline to mild cases (isolated at home) for 3 days and lopinavir plus doxycycline to moderate and severe cases (hospitalized) for 5 days. The overall case fatality rate was 4.2% (20/475). |*COVID-19 Drug Treatment[MESH] |*SARS-CoV-2[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Cohort Studies[MESH] |Doxycycline/*administration & dosage[MESH] |Drug Therapy, Combination[MESH] |Female[MESH] |Humans[MESH] |Hydroxychloroquine/administration & dosage[MESH] |Lopinavir/*administration & dosage[MESH] |Male[MESH]A novel approach to managing COVID-19 patients; results of lopinavir p(epmc).pdf DeepDyve Pubget Overpricing